Why Aegis Capital Loves Adamas...And How To Bet On Parkinson's Treatment By: Benzinga via Benzinga September 22, 2015 at 11:17 AM EDT The share price of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) has risen a little over 13 percent year-to-date. Aegis ... Read More >> Related Stocks: Adamas Pharma